Paul M. Silber
- Co-authors
- Albert P. LiKatie ChanPeter J. O’BrienChuang LuCharles E. RueggNicola J. HewittScott A. LloydKlaus Brendel
- Topics
- Pharmacogenetics and Drug Metabolism (7 papers)Drug Transport and Resistance Mechanisms (5 papers)Drug-Induced Hepatotoxicity and Protection (4 papers)
- Cited by
- PharmacologyHepatologyOncology
- Partner nations
- United StatesCanadaSwitzerland
In The Last Decade
Paul M. Silber
20 papers receiving 621 citations
Peers
Comparison fields: 5 of 89
- Pharmacology 359
- Oncology 203
- Molecular Biology 177
- Hepatology 130
- Biomedical Engineering 100
Countries citing papers authored by Paul M. Silber
This map shows the geographic impact of Paul M. Silber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul M. Silber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul M. Silber more than expected).
Fields of papers citing papers by Paul M. Silber
This network shows the impact of papers produced by Paul M. Silber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul M. Silber. The network helps show where Paul M. Silber may publish in the future.
Co-authorship network of co-authors of Paul M. Silber
This figure shows the co-authorship network connecting the top 25 collaborators of Paul M. Silber. A scholar is included among the top collaborators of Paul M. Silber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul M. Silber. Paul M. Silber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 12 | |
| 3 | 37 | |
| 4 | 50 | |
| 5 | O-24 Independent regulation of intrarenal angiotensin receptors expression during the development of cyclosporine A-induced hypertension(KIDNEYS AND URINARY EXCRETION SYSTEM)(GENERAL SESSION BY ORAL PRESENTATION)(Proceedings of the 31st Annual Meeting) | 2 |
| 6 | 25 | |
| 7 | 75 | |
| 8 | 57 | |
| 9 | 36 | |
| 10 | 1 | |
| 11 | 37 | |
| 12 | 49 | |
| 13 | 1 | |
| 14 | 240 | |
| 15 | The CTFA evaluation of alternatives program: an evaluation of In vitro alternatives to the draize primary eye irritation test (phase I) hydro-alcoholic formulations; a preliminary communication | 21 |
| 16 | On the comedogenic potential of quaternium-15 and DMDM hydantoin | 1 |
| 17 | 1 | |
| 18 | 1 | |
| 19 | 25 | |
| 20 | 7 |
About Paul M. Silber
Paul M. Silber is a scholar working on Pharmacology, Hepatology and Toxicology, having authored 20 papers that have together received 679 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (7 papers), Drug Transport and Resistance Mechanisms (5 papers) and Drug-Induced Hepatotoxicity and Protection (4 papers). The work is most often cited by research in Pharmacology (359 citations), Hepatology (130 citations) and Oncology (203 citations). Paul M. Silber has collaborated with scholars based in United States, Canada and Switzerland. Frequent co-authors include Albert P. Li, Katie Chan, Peter J. O’Brien, Chuang Lu, Charles E. Ruegg, Nicola J. Hewitt, Scott A. Lloyd, Klaus Brendel, A. Jay Gandolfi and Neil S. Jensen. Their work appears in journals such as Analytical Biochemistry, Biochemical Pharmacology and Cancer Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.